Ionis Pharmaceuticals (IONS) PT Lowered to $55 at BofA Securities
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $43.15 -5.68%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $55.00 (from $56.00) while maintaining a Buy rating.
You May Also Be Interested In
- Ionis Pharmaceuticals (IONS) PT Lowered to $70 at JPMorgan Amid Negative Sentiment
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- KEPCO (015760:KS) (KEP) PT Lowered to KRW26,000 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
